Detalhe da pesquisa
1.
TROPION-Breast01: Datopotamab deruxtecan vs chemotherapy in pre-treated inoperable or metastatic HR+/HER2- breast cancer.
Future Oncol
; 20(8): 423-436, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37387213
2.
Ado-trastuzumab emtansine (T-DM1) in HER2+ advanced breast cancer patients: does pretreatment with pertuzumab matter?
Future Oncol
; 13(30): 2791-2797, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-29182361
3.
Mediterranean diet and quality of life in women treated for breast cancer: A baseline analysis of DEDiCa multicentre trial.
PLoS One
; 15(10): e0239803, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33031478
4.
A meta-analytic review of the relationship of cancer coping self-efficacy with distress and quality of life.
Oncotarget
; 8(22): 36800-36811, 2017 May 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-28404938
5.
Eribulin for metastatic breast cancer (MBC) treatment: a retrospective, multicenter study based in Campania, south Italy (Eri-001 trial).
ESMO Open
; 2(2): e000176, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28761747
6.
Downregulation of androgen receptor is strongly associated with diabetes in triple negative breast cancer patients.
Am J Transl Res
; 8(8): 3530-9, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27648143